Δ9-THC (Namisol) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain: a Randomized, Double-blinded, Placebo-controlled, Parallel Design

Trial Profile

Δ9-THC (Namisol) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain: a Randomized, Double-blinded, Placebo-controlled, Parallel Design

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2015

At a glance

  • Drugs Dronabinol (Primary)
  • Indications Abdominal pain
  • Focus Therapeutic Use
  • Acronyms Delta-Pain-II
  • Most Recent Events

    • 27 Oct 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
    • 15 Nov 2012 Planned End Date changed from 1 Jan 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
    • 01 Sep 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2012-000730-19 ).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top